Background: The endocrine control of sebaceous follicles is complex in women. During aging, a decline in sebum output is often experienced. However, some women report increased seborrhea after the menopause. Objective: In this study, the follicular reservoir function was studied during the first decade following the menopause. Methods: Four evaluations were made at 3-week intervals in two parallel age-matched groups of 50 postmenopausal women receiving hormone replacement therapy (HRT) or not. The Sebumeter served to measure the casual sebum level and the sebum excretion rate on the forehead. In addition, a Visioscan® equipped with an ultraviolet-recording camera was used with and without lipid-sensitive tapes interposed between the camera and the skin surface. Follicular openings and sebum pore patterns were studied by image analysis. Results: There was enormous diversity among individual values of sebum output at the skin surface. In untreated women, a significant decline in sebum excretion rate accompanied by an increase in both the sebum replacement time and the mean pore size were evidenced during the first decade after the menopause. The sebum excretion rate and casual level showed a wide range of interindividual differences early after the menopause. These physiological changes were less prominent in women receiving HRT. Conclusion: Postmenopausal aging affects the sebum production, but HRT does not significantly control the complex process of seborrhea. However, HRT mitigates the progressive enlargement of the openings of the sebum follicular reservoir.

Keywords:
Menopause, Climacteric, Sebaceous gland, Sex hormone, Hormone replacement therapy
1.
Choudhry R, Hodgins MB, Van Der Kwast TH, Brinkmann AO, Boersma WJA: Localisation of androgen receptors in human skin by immunohistochemistry: Implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992;133:467–475.
2.
Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P: The androgen control of sebum production: Studies of subjects with dihydrotestosterone deficiency and complete androgen insensibility. J Clin Endocrinol Metab 1993;76:524–528.
3.
Giltay EJ, Gooren LJG: Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol 2000;85:2913–2921.
4.
Deplewski D, Rosenfield RL: Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999;140:4089–4094.
5.
Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette G: Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 1996;193:289–294.
6.
Piérard GE, Letawe C, Piérard-Franchimont C, Gaspard U: Analytic quantification of skin changes during climacteric aging and hormone replacement therapy; in Vellas B, Albarede JL, Garry PJ (eds): Women Aging and Health: Facts, Research and Intervention. Geriatrics Ser. Paris, Serdi, New York, Springer, 1998, pp 167–176.
7.
Pochi PE, Strauss JS, Downing D: Age-related changes in sebaceous gland activity. J Invest Dermatol 1979;73:108–111.
8.
Jacobsen E, Billings JK, Frantz RA, Kinney CK, Stewart ME, Downing DT: Age-related changes in sebum secretion rate in men and women. J Invest Dermatol 1985;85:483–485.
9.
Downing DT, Stewart ME, Strauss JS: Changes in sebum secretion and the sebaceous gland. Dermatol Clin 1986;4:419–423.
10.
Luderschmidt C, Kinderman D: Sebostasis of the aged. G Ital Chir Dermatol Oncol 1987;2:192–200.
11.
Piérard GE, Piérard-Franchimont C, Lê T, Lapière CM: Patterns of follicular sebum excretion rate during lifetime. Arch Dermatol Res 1987;279:S104–S107.
12.
Piérard GE, Piérard-Franchimont C, Marks R, Paye M, Rogiers V, the EEMCO group: EEMCO guidance for the in vivo evaluation of skin greasiness. Skin Pharmacol Appl Physiol 2000;13:372–389.
13.
Piérard GE: The quandary of climacteric skin ageing. Dermatology 1996;193:273–274.
14.
Piérard GE, Letawe C, Dowlati A, Piérard-Franchimont C: Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995;43:662–665.
15.
Castelo-Branco C, Figueras F, Martinez de Osaba MJ, Vanrell JA: Facial wrinkling in postmenopausal women: Effects of smoking status and hormone replacement therapy. Maturitas 1998;29:75–86.
16.
Piérard-Franchimont C, Cornil F, Dehavay J, Letot B, Deleixhe-Mauhin F, Piérard GE: Climacteric skin ageing of the face: A prospective longitudinal intent-to-treat on the effect of oral hormone replacement therapy. Maturitas 1999;32:87–93.
17.
Piérard GE, Piérard-Franchimont C, Vanderplaetsen S, Franchimont N, Gaspard U, Malaise M: Relationship between bone mass density and tensile strength of the skin in women. Eur J Clin Invest 2001;31:731–735.
18.
Paquet F, Piérard-Franchimont C, Fumal I, Goffin V, Paye M, Piérard GE: Sensitive skin at menopause: Dew point and electrometric properties of the stratum corneum. Maturitas 1998;28:221–227.
19.
Piérard-Franchimont C, Gaspard U, Lacante P, Slachmuylders P, Piérard GE: A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene. Eur J Contracept Repr Health Care 2000;5:275–286.
20.
Piérard GE, Cauwenbergh G: Modulation of sebum excretion from the follicular reservoir by a dichlorophenyl-imidazoldioxolan. Int J Cosmet Sci 1996;18:219–228.
21.
Piérard GE, Ries G, Cauwenbergh G: New insight in the topical management of excessive sebum flow at the skin surface. Dermatology 1998;196:126–129.
22.
Piérard-Franchimont C, Martalo O, Richard A, Rougier A, Piérard GE: Sebum rheology evaluated by two methods in vivo: Split-face study of the effect of a cosmetic formulation. Eur J Dermatol 1999;9:455–457.
23.
Bläuler M, Vaalasti A, Pauli SL, Ylikomi T, Joensuu T, Tuohimaa P: Location of androgen receptor in human skin. J Invest Dermatol 1991;97:264–268.
24.
Liang T, Hoyer S, Yu R, Soltani K, Lorincz AL, Hiipakka RA, Liao S: Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol 1993;100:663–666.
25.
Thiboutot D, Knaggs H, Gilliland K, Lin G: Activity of 5α-reductase and 17β-hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and without acne vulgaris. Dermatology 1998;196:38–42.
26.
Plewig G, Kligman AM: Proliferative activity of the sebaceous glands of the aged. J Invest Dermatol 1978;70:314–317.
27.
Guy R, Kealy T: Modeling the infundibulum in acne. Dermatology 1998;196:32–37.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.